Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Hsct at a Glance Publisher



Ghavamzadeh A1 ; Barkhordar M2
Authors
Show Affiliations
Authors Affiliations
  1. 1. Hematology Oncology and Stem Cell Transplantation Research Center, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Cancer and Cell Therapy Research Center, Tehran University of Medical Sciences, Tehran, Iran

Source: Cardiovascular Considerations in Hematopoietic Stem Cell Transplantation Published:2024


Abstract

Hematopoietic stem cell transplantationHematopoietic Stem Cell Transplantation (HSCT) (HSCT) is the treatment of choice for various pediatric and adult malignant and non-malignant diseases. Many advancements have been achieved to ensure that HSCTs are available and secure for every individual who has a clinical reason for performing it since its discovery as a curative option for either hereditary or inherited hematological illnesses at the beginning of the 1960s. Professor Ghavamzadeh Professor Ghavamzadeh and colleagues performed the first HSCT in Iran on March 13, 1991, at the Bone Marrow Transplant Department of Shariati Hospital in Tehran. Autologous and allogeneic stem cell transplants were conducted at Shariati Hospital's HORCSCT Hematology, Oncology, and Stem Cell Transplantation Research Center (HORCSCT), using bone marrow, peripheral blood, or umbilical cord blood stem cells as the graft sources. In the present chapter, we'll briefly consider the hematopoietic stem cell transplantation Hematopoietic Stem Cell Transplantation (HSCT) © Springer Nature Switzerland AG 2024. All rights reserved.
Related Docs
1. The Impact of Malnutrition on Mortality and Complications of Hematopoietic Stem Cell Transplantation in Patients With Acute Leukemia, Clinical Nutrition (2023)
Experts (# of related papers)
View all Related Experts
Maryam Barkhordar (1)
Seyed Asadollah Mousavi (1)